pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
VC-02
PEC-Direct
Type 1 Diabetes (Juvenile Diabetes)
ViaCyte, Inc.
0
catalysts
Phase 2
VCA-894A
Charcot-Marie-Tooth Disease Type II
$VNDA
Vanda Pharmaceuticals Inc.
0
catalysts
Phase 2
VCT-220
Obesity
CORXEL Pharmaceuticals (Shanghai) Co Ltd
0
catalysts
Phase 2
VG-161
← prev
page 29 of 50
next →
131
Pain
89
Neurology
1
Bile Duct Cancer (Cholangiocarcinoma)
Virogin Biotech Ltd
0
catalysts
Phase 2
VG-801
Unspecified Ophthalmological Disorders
VeonGen Therapeutics GmbH
0
catalysts
Phase 2
VH-4524184
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ViiV Healthcare UK Ltd
0
catalysts
Phase 2
VIM-0423
Dystonia
Vima Therapeutics Inc
0
catalysts
Phase 2
VK-5211
Bone Fracture
Androgen receptor
$VIK
Viking Holdings Ltd
0
catalysts
Phase 2
VL-PX10 + VL-P22
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Vitti Labs LLC
0
catalysts
Phase 2
VLP-001
Peanut Allergy
Allergy Therapeutics Plc
0
catalysts
Phase 2
VLPM-01
Malaria
VLP Therapeutics LLC
0
catalysts
Phase 2
VLS-1488
Ovarian Cancer
Volastra Therapeutics Inc
0
catalysts
Phase 2
VMPSY-002
Substance (Drug) Abuse
Vivamed BioPharma
0
catalysts
Phase 2
VMPSY-003
Opium (Opioid) Addiction
Vivamed BioPharma
0
catalysts
Phase 2
VMT-01
Metastatic Melanoma
$CATX
Perspective Therapeutics, Inc.
0
catalysts
Phase 2
VMT-a-NET
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
$CATX
Perspective Therapeutics, Inc.
0
catalysts
Phase 2
VNX-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Vironexis Biotherapeutics Inc
0
catalysts
Phase 2
VNX-202
Gastric Cancer
Vironexis Biotherapeutics Inc
0
catalysts
Phase 2
VP-001
Retinitis Pigmentosa (Retinitis)
PYC Therapeutics Ltd
0
catalysts
Phase 2
VR-101
Female Contraception
VaRi Bioscience GmbH
0
catalysts
Phase 2
VR-103
Endometriosis
VaRi Bioscience GmbH
0
catalysts
Phase 2
VT-3989
Malignant Pleural Mesothelioma
Vivace Therapeutics Inc
0
catalysts
Phase 2
VTR-297
Onychomycosis (Tinea Unguium)
$VNDA
Vanda Pharmaceuticals Inc.
0
catalysts
Phase 2
VTx-002
Amyotrophic Lateral Sclerosis
VectorY Therapeutics Inc
0
catalysts
Phase 2
VVN-001
Keratoconjunctivitis Sicca (Dry Eye)
VivaVision Biotech Ltd
0
catalysts
Phase 2
VVN-461
Ocular Inflammation
VivaVision Biotech Ltd
0
catalysts
Phase 2
VX-407
Polycystic Kidney Disease
$VERX
Vertex, Inc.
0
catalysts
Phase 2
VXAG-1.1NN
Norovirus Infections
$VXRT
Vaxart, Inc.
0
catalysts
Phase 2
VXM-01
Recurrent Glioblastoma Multiforme (GBM)
Vaximm AG
0
catalysts
Phase 2
VY-7523
Alzheimer's Disease
$VYGR
Voyager Therapeutics, Inc.
0
catalysts
